Furthermore, this anti-inflammatory effect of SC-1 is mediated via inhibition of p38 MAPK phosphorylation and then NF-κB activation leading to the mRNA expression associated with pro-inflammatory cytokines, IL-6, in human cancer cells. Here, NFKB1 is linked to cancer.